The process of aging population will inevitably increase age-related comorbidities including chronic kidney disease (CKD). In light of this demographic transition, the lack of an age-adjusted CKD classification may enormously increase the number of new diagnoses of CKD in old subjects with an indolent decline in kidney function. Overdiagnosis of CKD will inevitably lead to important clinical consequences and pronounced negative effects on the health-related quality of life of these patients. Based on these data, an appropriate workup for the diagnosis of CKD is critical in reducing the burden of CKD worldwide. Optimal management of CKD should be based on prevention and reduction of risk factors associated with kidney injury. Once the diagnosis of CKD has been made, an appropriate staging of kidney disease and timely prescriptions of promising nephroprotective drugs (e.g., RAAS, SGLT-2 inhibitors, finerenone) appear crucial to slow down the progression toward end-stage kidney disease (ESKD). The management of elderly, comorbid and frail patients also opens new questions on the appropriate renal replacement therapy for this subset of the population. The non-dialytic management of CKD in old subjects with short life expectancy features as a valid option in patient-centered care programs. Considering the multiple implications of CKD for global public health, this review examines the prevalence, diagnosis and principles of treatment of kidney disease in the aging population.

Rethinking Chronic Kidney Disease in the Aging Population / Alfano, Gaetano; Perrone, Rossella; Fontana, Francesco; Ligabue, Giulia; Giovanella, Silvia; Ferrari, Annachiara; Gregorini, Mariacristina; Cappelli, Gianni; Magistroni, Riccardo; Donati, Gabriele. - In: LIFE. - ISSN 2075-1729. - 12:11(2022), pp. 1724-1742. [10.3390/life12111724]

Rethinking Chronic Kidney Disease in the Aging Population

Alfano, Gaetano;Perrone, Rossella;Fontana, Francesco;Ligabue, Giulia;Giovanella, Silvia;Cappelli, Gianni;Magistroni, Riccardo;Donati, Gabriele
2022

Abstract

The process of aging population will inevitably increase age-related comorbidities including chronic kidney disease (CKD). In light of this demographic transition, the lack of an age-adjusted CKD classification may enormously increase the number of new diagnoses of CKD in old subjects with an indolent decline in kidney function. Overdiagnosis of CKD will inevitably lead to important clinical consequences and pronounced negative effects on the health-related quality of life of these patients. Based on these data, an appropriate workup for the diagnosis of CKD is critical in reducing the burden of CKD worldwide. Optimal management of CKD should be based on prevention and reduction of risk factors associated with kidney injury. Once the diagnosis of CKD has been made, an appropriate staging of kidney disease and timely prescriptions of promising nephroprotective drugs (e.g., RAAS, SGLT-2 inhibitors, finerenone) appear crucial to slow down the progression toward end-stage kidney disease (ESKD). The management of elderly, comorbid and frail patients also opens new questions on the appropriate renal replacement therapy for this subset of the population. The non-dialytic management of CKD in old subjects with short life expectancy features as a valid option in patient-centered care programs. Considering the multiple implications of CKD for global public health, this review examines the prevalence, diagnosis and principles of treatment of kidney disease in the aging population.
2022
12
11
1724
1742
Rethinking Chronic Kidney Disease in the Aging Population / Alfano, Gaetano; Perrone, Rossella; Fontana, Francesco; Ligabue, Giulia; Giovanella, Silvia; Ferrari, Annachiara; Gregorini, Mariacristina; Cappelli, Gianni; Magistroni, Riccardo; Donati, Gabriele. - In: LIFE. - ISSN 2075-1729. - 12:11(2022), pp. 1724-1742. [10.3390/life12111724]
Alfano, Gaetano; Perrone, Rossella; Fontana, Francesco; Ligabue, Giulia; Giovanella, Silvia; Ferrari, Annachiara; Gregorini, Mariacristina; Cappelli, ...espandi
File in questo prodotto:
File Dimensione Formato  
life-12-01724.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 969.23 kB
Formato Adobe PDF
969.23 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1291584
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 11
social impact